Kyeongjin Ahn

Title: Kyeongjin Ahn: Innovator in Pharmaceutical Composition

Introduction

Kyeongjin Ahn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug stability and patient compliance. With a total of 2 patents, Ahn's work is paving the way for advancements in medication formulations.

Latest Patents

Ahn's latest patents include a pharmaceutical composition comprising dutasteride and propylene glycol monolaurate. This invention focuses on improving the stability of dutasteride, a poorly soluble drug used as a 5-alpha reductase inhibitor. The patent details a process for preparing a capsule formulation that is smaller in size than the commercial dutasteride capsule formulation (AVODART®), while maintaining an equivalent dissolution rate. This innovative approach aims to enhance patient compliance and improve the overall stability of the dutasteride formulation.

Career Highlights

Kyeongjin Ahn is currently associated with Yuyu Pharma, Inc., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and stability has positioned him as a key player in the industry.

Collaborations

Ahn collaborates with talented individuals such as Seyeon Kim and Ju-hee Kim, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.

Conclusion

Kyeongjin Ahn's contributions to pharmaceutical compositions demonstrate his commitment to improving drug formulations and patient care. His innovative patents reflect a deep understanding of the challenges in the pharmaceutical industry and a dedication to finding effective solutions.